Glyscend Therapeutics announces preclinical data at ADA 2021 on the metabolic benefits of its oral polymer-based duodenal exclusion therapy
August 3, 2021

August 3, 2021
August 3, 2021
July 27, 2021
July 27, 2021
July 27, 2021
July 27, 2021
July 22, 2021
July 19, 2021
July 19, 2021
April 14, 2026
Collaboration supports global LRRK2 Investigative Therapeutics Exchange (LITE) to accelerate development of reliable biomarkers for Parkinson’s diseas...
April 13, 2026
Strengthens ECI’s senior advisory expertise across quality, regulatory, and strategic growth initiatives Enhanced Compliance Inc. (ECI), a global life...
April 2, 2026
The partnership pairs Pillar’s portfolio of oncoReveal® kitted NGS panels with CellCarta’s global laboratory network and biomarker expertise to reduce...

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225